Search
Search
Keith Barton, MD, FRCP, FRCS
Show Description +
Keith Barton, MD, FRCP, FRCS, overviews the Early Manifest Glaucoma Trial (EMGT), a study designed to evaluate the effects of treatment versus no treatment on early-stage glaucoma. Dr. Barton describes a few notable characteristics of the EMGT and its key findings.
Posted: 3/03/2018
Keith Barton, MD, FRCP, FRCS
Keith Barton, MD, FRCP, FRCS, overviews the Early Manifest Glaucoma Trial (EMGT), a study designed to evaluate the effects of treatment versus no treatment on early-stage glaucoma. Dr. Barton describes a few notable characteristics of the EMGT and its key findings.
Posted: 3/03/2018
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of AGS: 2018.
Please log in to leave a comment.